When Emma received a diagnosis of triple-negative breast cancer, she refused to let it dictate her future. Cancer can take away so much, but at Gilead, we’re striving to reclaim what it steals. Our commitment to redefining cancer treatment continues, and we’re excited to present our latest research at ASCO25.
Reclaiming Hope: Gilead’s Fight Against Triple-Negative Breast Cancer
